Intensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes

Figure 4

Freedom from relapse of 60 patients with hypopharyngeal-laryngeal cancer by stage (A = T2-T3 versus B = T4).